| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3070277 | Neurobiology of Disease | 2009 | 6 Pages |
Abstract
Our study shows that FK506 may not be suitable for the treatment of the human nerve disorders. Furthermore, when used as an immunosuppressant, the drug may generate detrimental neurological side effects in patients with an additional hereditary neuropathy.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Chi Wang Ip, Antje Kroner, Bianca Kohl, Carsten Wessig, Rudolf Martini,